Clinical Trial Update: First-line Treatment of Ewing Tumours With Primary Extrapulmonary Dissemination in Patients From 2 to 50 Years (CombinaiR3) [Phase 2]

View source ↗

Summary

The document reports the completion of a Phase 2 clinical trial (CombinaiR3) evaluating first-line treatment for Ewing sarcoma with primary extrapulmonary disse…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma

Snippet

Sponsor: Institut Curie | Conditions: Ewing Sarcoma Family of Tumors | Phase 2 | Status: COMPLETED